Hamilton Lane Incorporated
NASDAQ:HLNEAsset Management
+$1.08 today
- Market cap
- $4.84B
- Beta
- 1.16
- P/E (TTM)
- 13.8
- EPS (TTM)
- $5.97
- Dividend yield
- 2.69%
Volume 0.40M
Average 0.90M
HLNE Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Hamilton Lane IncorporatedNASDAQ: HLNE
Research & Development · Q1 FY2027 · quarter ended Jun 2026
Research & development remains negative
Q1 FY2027 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 0 | — |
| FY2025 | 2025-03-31 | 0 | — |
| FY2024 | 2024-03-31 | 0 | — |
| FY2023 | 2023-03-31 | 0 | — |
| FY2022 | 2022-03-31 | 0 | — |
Research & Development vs competitors
How HLNE compares with its peers on the latest reported figures
- HLNE's LTM Jun 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for HLNE, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding HLNE) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for HLNE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 367.92M | 528.75M | 553.84M | 712.96M | 758.99M |
| Cost of Revenue | 108.4M | 149.32M | 166.39M | 208.22M | 228.63M |
| Gross Profit | 259.52M | 379.44M | 387.45M | 504.74M | 530.36M |
| Gross Margin | 70.5% | 71.8% | 70.0% | 70.8% | 69.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 89.96M | 139.4M | 141.63M | 188.19M | 205.42M |
| Operating Expenses | 89.96M | 139.4M | 141.63M | 188.19M | 205.42M |
| Depreciation & Amortization | 5.5M | 7.44M | 8.19M | 9.29M | 9.88M |
| EBITDA | 323.81M | 258.67M | 301.02M | 384.89M | 487.75M |
| EBITDA Margin | 88.0% | 48.9% | 54.4% | 54.0% | 64.3% |
| Operating Income | 169.56M | 240.04M | 245.82M | 316.55M | 324.94M |
| Operating Margin | 46.1% | 45.4% | 44.4% | 44.4% | 42.8% |
| Interest Income | 500K | 5.11M | 10.01M | 8.08M | 13.28M |
| Interest Expense | 4.63M | 8.62M | 11.18M | 13.33M | 14.95M |
| Other Income / Expenses | 144.11M | 2.57M | 35.84M | 45.73M | 137.98M |
| Income Before Tax | 313.68M | 242.61M | 281.66M | 362.28M | 462.92M |
| Pre-Tax Margin | 85.3% | 45.9% | 50.9% | 50.8% | 61.0% |
| Income Tax Expense | 66.42M | 55.43M | 54.45M | 48.51M | 75.2M |
| Net Income | 145.99M | 109.12M | 140.86M | 217.42M | 249.18M |
| Net Margin | 39.7% | 20.6% | 25.4% | 30.5% | 32.8% |
| EPS (Basic) | 4.02 | 3.05 | 3.72 | 5.45 | 5.99 |
| EPS (Diluted) | 3.98 | 3.01 | 3.69 | 5.41 | 5.92 |
| Weighted Avg Shares | 36.51M | 37.06M | 37.86M | 40.15M | 37.1M |
| Weighted Avg Shares (Diluted) | 53.67M | 53.7M | 53.9M | 47.73M | 54.5M |
Hamilton Lane Incorporated
NASDAQ:HLNE
Intrinsic Alpha fair value
Locked
Current Price
$87.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.